R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis is a research paper published in Molecular Cell (2021). On theSindex it has a DataRank of 0. It has been cited 354 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA243386
National Institutes of Health
Grant: R01 CA214965
National Institutes of Health
Grant: R01 CA236399
National Institutes of Health
Grant: R01 CA211614
National Institutes of Health
Grant: R01 DK124116
NCI NIH HHS
Grant: R01 CA169458
NCI NIH HHS
Grant: R01 CA172558
NCI NIH HHS
Grant: U10 CA180827
NCI NIH HHS
Grant: R35 CA197628
NCI NIH HHS
Grant: R01 CA157644
NCI NIH HHS
Grant: R01 CA137060
NCI NIH HHS
Grant: T32 CA186895
European Hematology Association
Grant: TRTH127
NCI NIH HHS
Grant: R01 CA213138
Howard Hughes Medical Institute
American Association for Cancer Research
Leukemia and Lymphoma Society
American Cancer Society
Howard Hughes Medical Institute
FWCI
23.10
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals